---
title: "PU Prime launches second phase of 'Champion in You' global campaign, 'The Grind', focusing on post-trade routines."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274777652.md"
description: "In EBENE, Mauritius on February 4, 2026, PU Prime introduced The Grind, the next segment of its 'Champion in You' global brand campaign. This marks the second phase out of the three parts, with a transition from the commencement of trading to the subsequent stages. The Grind spotlights the post-start phase, underscoring the importance of routines and activities that follow the initial decision-making process."
datetime: "2026-02-04T07:52:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274777652.md)
  - [en](https://longbridge.com/en/news/274777652.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274777652.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/274777652.md) | [繁體中文](https://longbridge.com/zh-HK/news/274777652.md)


# PU Prime launches second phase of 'Champion in You' global campaign, 'The Grind', focusing on post-trade routines.

In EBENE, Mauritius on February 4, 2026, PU Prime introduced The Grind, the next segment of its 'Champion in You' global brand campaign. This marks the second phase out of the three parts, with a transition from the commencement of trading to the subsequent stages. The Grind spotlights the post-start phase, underscoring the importance of routines and activities that follow the initial decision-making process.

## Related News & Research

- [HiTek Global to Enact 50-for-1 Reverse Split to Maintain Nasdaq Listing](https://longbridge.com/en/news/281398004.md)
- [Rentomojo IPO: Accel India IV (Mauritius) Limited to sell 7.8 mln shares](https://longbridge.com/en/news/280835904.md)
- [Euna Solutions Opens Nominations for 2026 Euna Impact Awards](https://longbridge.com/en/news/281505901.md)
- [BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | BCRX Stock News](https://longbridge.com/en/news/281630381.md)
- [Lupin Receives Tentative U.S. FDA Approval For Sugammadex Injection](https://longbridge.com/en/news/281212760.md)